Raymond James Reinstates Market Perform on Qualcomm

Raymond James analyst Srini Pajjuri reinstates Qualcomm (NASDAQ:QCOM) with a Market Perform.

byBenzinga Newsdesk

March 2, 2023

1 minute read

Raymond James analyst Srini Pajjuri reinstates Qualcomm (NASDAQ:QCOM) with a Market Perform.

Barclays Maintains Equal-Weight on AT&T, Raises Price Target to $19

By Benzinga Newsdesk

Today, 4:04 AM

Barclays analyst Kannan Venkateshwar maintains AT&T (NYSE:T) with a Equal-Weight and raises the price target from $18 to $19.

OpenSea Addresses The ‘Elephant In The Room’ — The Sale Of Stolen NFTs

By Samyuktha Sriram

Today, 4:04 AM

Decentralized NFT marketplace OpenSea addressed its policy regarding the sale of stolen items on its platform. What Happened: In a series of tweets on Thursday, OpenSea said it plans to incorporate user input in preventing the sale of stolen NFT.

BTC

5 Picks From ‘Rich Dad Poor Dad’ Author Robert Kiyosaki’s Crypto Expert

By Adrian Zmudzinski

Today, 4:04 AM

Editor's note: This story has been corrected to reflect that Jeff Wang is the founder of Rocketfuel Crypto. The story previously misidentified Wang as working at another firm.

$CHZ

NeuBase Therapeutics Reports Business Update And Financial Results For Q1 Of FY23; As Of December 31, 2022, The Company Had Cash And Cash Equivalents Of ~$17.4M

By Happy Mohamed

Today, 4:04 AM

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company"), a biotechnology platform company Drugging the Genome™ to address disease at the base level using a new class of precision

NBSE

Raymond James Reinstates Market Perform on Qualcomm

Related Posts

Barclays Maintains Equal-Weight on AT&T, Raises Price Target to $19

OpenSea Addresses The ‘Elephant In The Room’ — The Sale Of Stolen NFTs

5 Picks From ‘Rich Dad Poor Dad’ Author Robert Kiyosaki’s Crypto Expert

NeuBase Therapeutics Reports Business Update And Financial Results For Q1 Of FY23; As Of December 31, 2022, The Company Had Cash And Cash Equivalents Of ~$17.4M